Transforming Vaccination Globally, Regionally, Nationally 2021

“‘Transforming Vaccination Globally, Regionally and Nationally’ 2021: Accelerating equity, access and sustainability through policy development and implementation” programme

The 2020 FIP digital programme, entitled: Transforming Vaccination Globally and Regionally was the first FIP outcome-based online programme of its kind, which culminated in the signing of a FIP Commitment to Action on Improving Vaccination Coverage Through Pharmacies by FIP and member organisations to transform vaccinations globally and regionally. Building on the outcomes of the 2020 programme, the FIP 2021 digital programme focuses on supporting FIP members in accelerating programmes of equity, access and sustainability of vaccinations through policy development and implementation. The 12 events explore equity in vaccinations across the different angles of age, gender, literacy & education, and interprofessional unity & collaboration. Regional roundtables will discuss and identify priorities for sustainable access to vaccinations through pharmacies around the world. The programme will result in a FIP commitment to accelerate equity, access and sustainability through policy development and implementation, as well as a special policy collection capturing the outcomes of this transformation programme.

Pharmacist vaccinators and communicable disease management: FIP DG 16 Communicable Diseases

A webinar organised by: Vaccination
10 November 2020


In this episode – “Pharmacist Vaccinators and Communicable Disease Management” – is an interview format that focuses on the FIP Development Goal 16: communicable and Vector Diseases from the perspective of vaccination by a pharmacist. The role of vaccination in the prevention and suppression of communicable and vector-borne disease, and the promise of addressing these diseases that pharmacists vaccinators will deliver.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 16: Communicable and Vector Diseases in the Transformation of Vaccination Globally and Regionally

Interviewer:
Catherine Duggan, CEO, International Pharmaceutical Federation (FIP) - UK

Interviewee:
Michael Klepser, Past President - Society of Infectious Diseases Pharmacists; Professor of Pharmacy Practice, Ferris State University - USA

Pharmacist vaccinators and communicable disease management: FIP DG 16 Communicable Diseases

A webinar organised by: Vaccination
10 November 2020


In this episode – “Pharmacist Vaccinators and Communicable Disease Management” – is an interview format that focuses on the FIP Development Goal 16: communicable and Vector Diseases from the perspective of vaccination by a pharmacist. The role of vaccination in the prevention and suppression of communicable and vector-borne disease, and the promise of addressing these diseases that pharmacists vaccinators will deliver.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 16: Communicable and Vector Diseases in the Transformation of Vaccination Globally and Regionally

Interviewer:
Catherine Duggan, CEO, International Pharmaceutical Federation (FIP) - UK

Interviewee:
Michael Klepser, Past President - Society of Infectious Diseases Pharmacists; Professor of Pharmacy Practice, Ferris State University - USA

Pharmacist vaccinators and communicable disease management: FIP DG 16 Communicable Diseases

A webinar organised by: Vaccination
10 November 2020


In this episode – “Pharmacist Vaccinators and Communicable Disease Management” – is an interview format that focuses on the FIP Development Goal 16: communicable and Vector Diseases from the perspective of vaccination by a pharmacist. The role of vaccination in the prevention and suppression of communicable and vector-borne disease, and the promise of addressing these diseases that pharmacists vaccinators will deliver.

About the Series: The second of three series is composed of 8 episodes that focus on The FIP Development Goals from the perspective of vaccination. The new FIP Development Goals and the agenda of improving vaccination worldwide come together in this series of interviews that outline how pharmacists and pharmaceutical scientists will deliver on the promise of improved vaccination rates worldwide.

Series 2 will identify the alignment of the goal of improved vaccination rates worldwide through the use of the pharmacist workforce with the FIP Development Goals.

Objective
To understand the impact of FIP Development Goal 16: Communicable and Vector Diseases in the Transformation of Vaccination Globally and Regionally

Interviewer:
Catherine Duggan, CEO, International Pharmaceutical Federation (FIP) - UK

Interviewee:
Michael Klepser, Past President - Society of Infectious Diseases Pharmacists; Professor of Pharmacy Practice, Ferris State University - USA